Resultados de la búsqueda 741-750 of 11277 for Epilepsy (Partial Onset)

1. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   The study hypothesis is that the progressively increased interval duration at high-intensity (PRO-HIIT) will result in a greater increases in fitness, heart ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... focal external beam radiation, and dinutuximab immunotherapy with isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Senescent cells contribute to age-related tissue deterioration, inflammation, and fibrosis. A group of novel frailty biomarkers obtained at the time of ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. Obstetricia y Ginecología - Ensayos clínicos - Mayo Clinic

   This study is being conducted to see if adding Exemestane to the immune checkpoint blockade can slow disease progression in post-menopausal women with non-small ...

7. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to establish a registry that will address the data gap regarding the course of NSTEMI (Non-ST-Elevation Myocardial Infarction) ...

8. Epilepsia - Médicos y departamentos - Mayo Clinic

   Áreas donde se investiga este trastorno · Neurologic Surgery · Neurology Research · Radiology Research ...

9. Salud de bebés y niños pequeños Lifestyle 2 - Mayo Clinic

   News · octubre 2024 · septiembre 2024 · agosto 2024 · julio 2024 · mayo 2024 · abril 2024 · marzo 2024 · febrero 2024.

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...